Philippe Duchateau

Person

Cemy, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Method for improving production of car T cells
- Patent number 12,365,733
- Issue date Jul 22, 2025
- Cellectis
- Alex Boyne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for generating t-cells compatible for allogenic transplantation
- Patent number 12,252,699
- Issue date Mar 18, 2025
- Cellectis
- Laurent Poirot
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted gene integration of CRS inhibitor genes for improved immun...
- Patent number 12,221,478
- Issue date Feb 11, 2025
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted gene integration of NK inhibitors genes for improved immun...
- Patent number 12,209,125
- Issue date Jan 28, 2025
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cellular immunotherapy for repetitive administration
- Patent number 12,144,825
- Issue date Nov 19, 2024
- Cellectis
- David Sourdive
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering T cells for immunotherapy by using RNA-guid...
- Patent number 11,959,091
- Issue date Apr 16, 2024
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Universal anti-CD22 chimeric antigen receptor engineered immune cells
- Patent number 11,944,643
- Issue date Apr 2, 2024
- Cellectis SA
- Julianne Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors targeting B-cell maturation antigen
- Patent number 11,912,776
- Issue date Feb 27, 2024
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered immune cells resistant to tumor microenvironment
- Patent number 11,903,968
- Issue date Feb 20, 2024
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted gene insertion for improved immune cells therapy
- Patent number 11,873,511
- Issue date Jan 16, 2024
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for generating T-cells compatible for allogenic transplantation
- Patent number 11,820,996
- Issue date Nov 21, 2023
- Cellectis
- Laurent Poirot
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Repeat variable diresidues for targeting nucleotides
- Patent number 11,778,993
- Issue date Oct 10, 2023
- Cellectis, S.A.
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Sequence specific reagents targeting CCR5 in primary hematopoietic...
- Patent number 11,767,512
- Issue date Sep 26, 2023
- Cellectis
- Toni Cathomen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Universal chimeric antigen receptor T cells specific for CD22
- Patent number 11,690,873
- Issue date Jul 4, 2023
- Cellectis SA
- Cecile Schiffer-Mannioui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cells for immunotherapy engineered for targeting antigen present bo...
- Patent number 11,692,169
- Issue date Jul 4, 2023
- Cellectis
- Philippe Duchateau
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Compact scaffold of Cas9 in the type II CRISPR system
- Patent number 11,685,935
- Issue date Jun 27, 2023
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Sequential gene editing in primary immune cells
- Patent number 11,674,155
- Issue date Jun 13, 2023
- Cellectis
- Jean-Pierre Cabaniols
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Sequential gene editing in primary immune cells
- Patent number 11,466,291
- Issue date Oct 11, 2022
- Cellectis
- Jean-Pierre Cabaniols
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering T cells for immunotherapy by using RNA-guid...
- Patent number 11,365,430
- Issue date Jun 21, 2022
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptors targeting B-cell maturation antigen
- Patent number 11,312,782
- Issue date Apr 26, 2022
- Pfizer Inc.
- Tracy Chia-Chien Kuo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method to overcome DNA chemical modifications sensitivity of engine...
- Patent number 11,220,683
- Issue date Jan 11, 2022
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for the generation of compact tale-nucleases and uses thereof
- Patent number 11,198,856
- Issue date Dec 14, 2021
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering allogeneic T cell to increase their persist...
- Patent number 11,186,824
- Issue date Nov 30, 2021
- Cellectis
- Philippe Duchateau
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Tale-protein scaffolds and uses thereof
- Patent number 11,136,566
- Issue date Oct 5, 2021
- Cellectis
- Philippe Duchateau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs)...
- Patent number 11,014,989
- Issue date May 25, 2021
- Cellectis
- Julianne Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors with integrated controllable functions
- Patent number 10,988,542
- Issue date Apr 27, 2021
- Cellectis
- Alexandre Juillerat
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of engineering drug-specific hypersensitive t-cells for immu...
- Patent number 10,894,093
- Issue date Jan 19, 2021
- Cellectis
- Julien Valton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering T cells for immunotherapy by using RNA-guid...
- Patent number 10,870,864
- Issue date Dec 22, 2020
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cells for immunotherapy engineered for targeting antigen present bo...
- Patent number 10,836,998
- Issue date Nov 17, 2020
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of engineering chemotherapy drug resistant T-cells for immun...
- Patent number 10,813,951
- Issue date Oct 27, 2020
- Cellectis
- Julien Valton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
ENHANCING EFFICACY OF T-CELL-MEDIATED IMMUNOTHERAPY BY MODULATING C...
- Publication number 20250057952
- Publication date Feb 20, 2025
- CELLECTIS S.A.
- Shipra DAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION
- Publication number 20250034641
- Publication date Jan 30, 2025
- CELLECTIS
- David SOURDIVE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NEW TALE PROTEIN SCAFFOLDS WITH IMPROVED ON-TARGET/OFF-TARGET ACTIV...
- Publication number 20250002945
- Publication date Jan 2, 2025
- CELLECTIS S.A.
- Philippe DUCHATEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR THE TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY...
- Publication number 20240318154
- Publication date Sep 26, 2024
- CELLECTIS
- Toni CATHOMEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR THE TREATMENT OF HYPER-IgE SYNDROME (HIES) BY TARG...
- Publication number 20240299453
- Publication date Sep 12, 2024
- CELLECTIS S.A.
- Toni Cathomen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING...
- Publication number 20240228636
- Publication date Jul 11, 2024
- CELLECTIS
- Barbara Johnson SASU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY
- Publication number 20240141293
- Publication date May 2, 2024
- CELLECTIS
- Brian BUSSER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR GENERATING T-CELLS COMPATIBLE FOR ALLOGENIC TRANSPLANTATION
- Publication number 20240026376
- Publication date Jan 25, 2024
- CELLECTIS
- Laurent POIROT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF AMINOQUINOLINE COMPOUNDS FOR HIGHER GENE INTEGRATION
- Publication number 20230416786
- Publication date Dec 28, 2023
- CELLECTIS S.A.
- Alexandre JUILLERAT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BO...
- Publication number 20230357719
- Publication date Nov 9, 2023
- CELLECTIS
- Philippe DUCHATEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SEQUENTIAL GENE EDITING IN PRIMARY IMMUNE CELLS
- Publication number 20230287454
- Publication date Sep 14, 2023
- CELLECTIS
- Jean-Pierre CABANIOLS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PRO...
- Publication number 20230279440
- Publication date Sep 7, 2023
- CELLECTIS S.A.
- Alexandre JUILLERAT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DUAL CAR-T CELLS
- Publication number 20230279350
- Publication date Sep 7, 2023
- CELLECTIS S.A.
- André CHOULIKA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS
- Publication number 20230248825
- Publication date Aug 10, 2023
- CELLECTIS S.A.
- Shipra DAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TARGETED INSERTION OF EXOGENOUS SEQUENCES IN CELLULAR G...
- Publication number 20230212613
- Publication date Jul 6, 2023
- CELLECTIS S.A.
- Ming YANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION COMPRISING ALLOGENEIC IMMUNE CELLS DEFICIENT FOR AN ANT...
- Publication number 20230158070
- Publication date May 25, 2023
- CELLECTIS
- Philippe DUCHATEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TAL- effector nuclease (TALEN) -MODIFIED ALLOGENIC CELLS SUITABLE F...
- Publication number 20230138915
- Publication date May 4, 2023
- CELLECTIS
- Philippe DUCHATEAU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEQUENTIAL GENE EDITING IN PRIMARY IMMUNE CELLS
- Publication number 20230087122
- Publication date Mar 23, 2023
- CELLECTIS
- Jean-Pierre CABANIOLS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
New mesothelin specific chimeric antigen receptors (CAR) for solid...
- Publication number 20230068949
- Publication date Mar 2, 2023
- CELLECTIS
- Cecile SCHIFFER-MANNIOUI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN
- Publication number 20220340671
- Publication date Oct 27, 2022
- Pfizer Inc.
- TRACY CHIA-CHIEN KUO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION
- Publication number 20220233588
- Publication date Jul 28, 2022
- CELLECTIS
- David SOURDIVE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR THE GENERATION OF COMPACT TALE-NUCLEASES AND USES THEREOF
- Publication number 20220010292
- Publication date Jan 13, 2022
- CELLECTIS
- Philippe Duchateau
- C07 - ORGANIC CHEMISTRY
Information Patent Application
UNIVERSAL ANTI-CD22 CHIMERIC ANTIGEN RECEPTOR ENGINEERED IMMUNE CELLS
- Publication number 20210161954
- Publication date Jun 3, 2021
- CELLECTIS S.A.
- Julianne Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUID...
- Publication number 20210147868
- Publication date May 20, 2021
- CELLECTIS
- Philippe DUCHATEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-HBV COMBINATION THERAPIES INVOLVING SPECIFIC ENDONUCLEASES
- Publication number 20210139870
- Publication date May 13, 2021
- CELLECTIS
- Philippe DUCHATEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED IMMUNE CELLS RESISTANT TO TUMOR MICROENVIRONMENT
- Publication number 20210128613
- Publication date May 6, 2021
- CELLECTIS
- Philippe DUCHATEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NEW UNIVERSAL CHIMERIC ANTIGEN RECEPTOR T CELLS SPECIFIC FOR CD22
- Publication number 20210100839
- Publication date Apr 8, 2021
- CELLECTIS S.A.
- Cecile Schiffer-Mannioui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TALE-NUCLEASES FOR ALLELE-SPECIFIC CODON MODIFICATION AND MULTIPLEXING
- Publication number 20210017545
- Publication date Jan 21, 2021
- CELLECTIS
- Alex BOYNE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BO...
- Publication number 20200407682
- Publication date Dec 31, 2020
- CELLECTIS
- Philippe DUCHATEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED GENE INTEGRATION OF CRS INHIBITOR GENES FOR IMPROVED IMMUN...
- Publication number 20200407694
- Publication date Dec 31, 2020
- CELLECTIS
- Brian BUSSER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Philippe Duchateau

Person

Patents Grantslast 30 patents

Method for improving production of car T cells

Method for generating t-cells compatible for allogenic transplantation

Targeted gene integration of CRS inhibitor genes for improved immun...

Targeted gene integration of NK inhibitors genes for improved immun...

Cellular immunotherapy for repetitive administration

Methods for engineering T cells for immunotherapy by using RNA-guid...

Universal anti-CD22 chimeric antigen receptor engineered immune cells

Chimeric antigen receptors targeting B-cell maturation antigen

Engineered immune cells resistant to tumor microenvironment

Targeted gene insertion for improved immune cells therapy

Method for generating T-cells compatible for allogenic transplantation

Repeat variable diresidues for targeting nucleotides

Sequence specific reagents targeting CCR5 in primary hematopoietic...

Universal chimeric antigen receptor T cells specific for CD22

Cells for immunotherapy engineered for targeting antigen present bo...

Compact scaffold of Cas9 in the type II CRISPR system

Sequential gene editing in primary immune cells

Sequential gene editing in primary immune cells

Methods for engineering T cells for immunotherapy by using RNA-guid...

Chimeric antigen receptors targeting B-cell maturation antigen

Method to overcome DNA chemical modifications sensitivity of engine...

Method for the generation of compact tale-nucleases and uses thereof

Methods for engineering allogeneic T cell to increase their persist...

Tale-protein scaffolds and uses thereof

Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs)...

Chimeric antigen receptors with integrated controllable functions

Method of engineering drug-specific hypersensitive t-cells for immu...

Methods for engineering T cells for immunotherapy by using RNA-guid...

Cells for immunotherapy engineered for targeting antigen present bo...

Method of engineering chemotherapy drug resistant T-cells for immun...

Patents Applicationslast 30 patents

ENHANCING EFFICACY OF T-CELL-MEDIATED IMMUNOTHERAPY BY MODULATING C...

CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION

NEW TALE PROTEIN SCAFFOLDS WITH IMPROVED ON-TARGET/OFF-TARGET ACTIV...

GENE THERAPY FOR THE TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY...

GENE THERAPY FOR THE TREATMENT OF HYPER-IgE SYNDROME (HIES) BY TARG...

mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING...

TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY

METHOD FOR GENERATING T-CELLS COMPATIBLE FOR ALLOGENIC TRANSPLANTATION

USE OF AMINOQUINOLINE COMPOUNDS FOR HIGHER GENE INTEGRATION

CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BO...

SEQUENTIAL GENE EDITING IN PRIMARY IMMUNE CELLS

METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PRO...

DUAL CAR-T CELLS

T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS

METHODS FOR TARGETED INSERTION OF EXOGENOUS SEQUENCES IN CELLULAR G...

COMBINATION COMPRISING ALLOGENEIC IMMUNE CELLS DEFICIENT FOR AN ANT...

TAL- effector nuclease (TALEN) -MODIFIED ALLOGENIC CELLS SUITABLE F...

SEQUENTIAL GENE EDITING IN PRIMARY IMMUNE CELLS

New mesothelin specific chimeric antigen receptors (CAR) for solid...

CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN

CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION

METHOD FOR THE GENERATION OF COMPACT TALE-NUCLEASES AND USES THEREOF

UNIVERSAL ANTI-CD22 CHIMERIC ANTIGEN RECEPTOR ENGINEERED IMMUNE CELLS

METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUID...

ANTI-HBV COMBINATION THERAPIES INVOLVING SPECIFIC ENDONUCLEASES

ENGINEERED IMMUNE CELLS RESISTANT TO TUMOR MICROENVIRONMENT

NEW UNIVERSAL CHIMERIC ANTIGEN RECEPTOR T CELLS SPECIFIC FOR CD22

TALE-NUCLEASES FOR ALLELE-SPECIFIC CODON MODIFICATION AND MULTIPLEXING

CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BO...

TARGETED GENE INTEGRATION OF CRS INHIBITOR GENES FOR IMPROVED IMMUN...